Skin & hair

Melanoma Staging — What Each Stage Means

Save

A melanoma diagnosis comes with a stage — a shorthand for how deep the tumor is and whether it has moved beyond where it started. Doctors use the AJCC system, built on tumor thickness, ulceration, and lymph-node involvement. This guide explains what each stage from 0 to IV means, how the stage is worked out, and why an accurate biopsy matters so much.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

What are the stages of melanoma?

Melanoma is staged on a scale from 0 to IV, and the number is a shorthand for how far the cancer has traveled from where it began. Stage 0 sits only in the top layer of skin. Stages I and II are tumors still confined to the skin, sorted mainly by how thick they are and whether the surface is broken. Stage III means the melanoma has reached nearby lymph nodes or skin, and Stage IV means it has spread to distant parts of the body 1. The staging system doctors use is the AJCC system, and it draws on the pathologist's report far more than on how the spot looked to the eye 2.

A stage is not a verdict you can assign yourself from a photograph or a symptom. It comes from measurements made under a microscope after the tumor is removed, sometimes combined with imaging and a lymph-node procedure. The stage of a melanoma is determined by your pathology report and your care team — not by appearance, and not by anything you can read off a screen. Knowing what the stages mean, though, makes those conversations far less frightening.

StageWhat it broadly means
Stage 0 (in situ)Melanoma cells confined to the top layer of skin; has not invaded deeper
Stage IThin, localized tumor with no sign of spread
Stage IIThicker and/or ulcerated, still localized, nodes not involved
Stage IIISpread to regional lymph nodes, or to nearby skin (satellite or in-transit)
Stage IVSpread to distant skin, lymph nodes, or organs

How is the stage worked out?

The stage is built from three things a pathologist and care team assess, known together as the TNM system: the tumor itself (T), the lymph nodes (N), and whether there is distant spread (M). For the tumor, the two measurements that matter most are its Breslow thickness — how deep the melanoma cells reach, measured in millimetres — and whether the surface is ulcerated. Thicker and ulcerated tumors are staged higher 1.

The classic thickness bands run roughly like this: tumors up to about 1 mm are the thinnest category, then more than 1 up to 2 mm, more than 2 up to 4 mm, and thicker than 4 mm. The AJCC eighth edition refined how these cutoffs and ulceration combine into stage groups, which is why an older description of melanoma staging may not match a current report 1. Some subtypes, such as nodular melanoma, tend to be measured thicker at diagnosis because they grow downward quickly rather than spreading outward first, which is part of why they are caught at a higher stage 2. Understanding your own Breslow thickness is one of the most useful numbers to ask about, because it drives both the stage and the width of the surgery that follows.

Why the biopsy technique matters for staging

Because thickness sets the stage, how the sample is taken matters a great deal. For a spot that might be melanoma, clinicians generally prefer to remove the whole lesion with a narrow margin — an excisional or saucerization biopsy that captures the full depth — rather than shaving off only the top or sampling a fragment, because a partial sample can under-measure the Breslow thickness and blur the stage 3. The AAD melanoma guideline describes these preferred biopsy techniques and why full-thickness sampling protects staging accuracy 4. It is also why a shave biopsy, perfectly reasonable for many other skin growths, is generally avoided when melanoma is suspected: shaving across the base can leave the true depth unknown and force the staging to lean on an incomplete measurement 3.

This is also why a definitive stage sometimes takes more than one procedure. The first biopsy confirms the diagnosis and gives an initial thickness; a wider excision afterward, and in some cases a lymph-node procedure, complete the picture. If a report is preliminary, it is reasonable to ask whether the thickness is final or whether the wider excision might change it. None of this is something a patient controls, but knowing the sequence makes an anxious wait more legible and the follow-up appointments easier to prepare for.

Stage 0: melanoma in situ

Stage 0 melanoma, also called melanoma in situ, means the abnormal cells are confined to the epidermis — the skin's outermost layer — and have not invaded the deeper dermis where they could reach blood vessels and lymphatic channels. Because it has not gone deep, melanoma in situ has not gained the ability to spread, and it is treated by surgically removing it with a margin of normal skin around it 2.

Stage 0 is the earliest and most favorable point at which melanoma is caught, which is the entire argument for noticing changes early. The treatment is local surgery rather than the systemic therapies used for advanced disease 4. For melanoma in situ on the face — particularly the lentigo maligna type that arises on chronically sun-damaged skin — staged excision or Mohs surgery is sometimes used to check the margins carefully while sparing tissue. Because melanoma in situ has not invaded, it is not assigned lymph-node or metastasis categories at all; the whole assessment is about clearing the surface lesion completely 2. The message worth holding on to is that a Stage 0 diagnosis, frightening as it is to hear, describes melanoma at its most treatable.

Stage I and II: localized melanoma

Stage I and Stage II melanomas are both still localized — confined to the skin, with no evidence of spread to lymph nodes or distant sites — and the split between them comes down to thickness and ulceration. A thin, non-ulcerated tumor falls into Stage I; a thicker or ulcerated one, still without nodal spread, falls into Stage II 1. Both are treated primarily with surgery.

The standard treatment is a wide local excision: the site of the melanoma is removed again with a wider margin of healthy skin, the width chosen according to the tumor's thickness 4. For tumors above a certain thickness, or with other higher-risk features, the care team may discuss a sentinel lymph node biopsy — a procedure that samples the first lymph node the area drains to, checking for microscopic spread and refining the stage 2. Whether a sentinel lymph node biopsy is offered depends on the tumor's thickness and features and on a frank discussion of what a positive or negative result would change; for the thinnest tumors it is often not recommended at all 4. A Stage I or II label means the melanoma has not been shown to travel, and the plan is built around removing it completely and confirming the nodes are clear.

Stage III: spread to nearby nodes or skin

Stage III melanoma means the cancer has reached the regional lymph nodes, or has traveled a short distance through nearby skin or lymphatic channels — called satellite or in-transit disease — but has not spread to distant organs. It is often found when a sentinel lymph node biopsy done for a thicker primary tumor comes back positive, and it spans a wide range, from a single microscopic node deposit to clearly enlarged nodes 2.

How the nodes are handled has changed. A large randomized trial found that immediately removing all the remaining lymph nodes after a positive sentinel node improved control of disease in that area and gave prognostic information, but did not lengthen melanoma-specific survival compared with careful ultrasound monitoring — so nodal observation is now a reasonable option for many people rather than automatic further surgery 5. Stage III is also where additional (adjuvant) drug therapy after surgery enters the conversation, using immunotherapy or targeted therapy to lower the chance of return 2. The wide range within Stage III is why two people who share the stage number can be in quite different situations — from a single microscopic focus found only under the microscope to clearly palpable nodal disease — and why the substage matters as much as the stage 1. This is a stage where a second opinion and a specialized melanoma team are especially worth seeking.

Stage IV: distant spread

Stage IV melanoma means the cancer has spread beyond the regional nodes to distant sites — most often other areas of skin and distant lymph nodes, the lungs, liver, bone, or brain. It is staged by where the spread is found and by certain blood markers, and the workup usually involves imaging in addition to biopsy 2. This is the most advanced stage, and it is also the area where treatment has changed the most in the last decade.

The mainstays are no longer chemotherapy but immunotherapy — drugs that release the brakes on the immune system so it can attack the melanoma — and targeted therapy for tumors carrying particular mutations such as BRAF. Surgery and radiation still have roles for specific sites 2. A Stage IV diagnosis is serious, but it is no longer a single fixed prognosis; outcomes vary widely with how the tumor responds, which is why care at a center experienced in advanced melanoma matters. What one person's Stage IV means cannot be read from a page — it is a conversation with an oncology team.

What does the stage mean for outlook?

Stage is the strongest single predictor of melanoma outlook, which is why so much care goes into getting it right. In broad terms, melanoma found while still localized to the skin has a high five-year relative survival; survival is lower once it has reached regional lymph nodes, and lower again with distant spread 6. Those are population figures, not personal forecasts — they describe large groups, and no statistic can tell an individual how their own melanoma will behave. Staging is also redone if the picture changes: a recurrence or newly found spread is re-evaluated rather than assumed, because treatment is matched to the current stage, not the one at first diagnosis 2.

Because the numbers shift meaningfully by stage, the melanoma survival rate by stage is worth understanding in its own right, and it is the single most compelling reason to have a changing mole looked at early rather than late. The gap between a thin, localized melanoma and one that has spread is the difference early detection buys. It is also why knowing your melanoma warning signs and getting a suspicious, evolving spot examined promptly is not caution for its own sake — it is the part of the outcome still within reach. A stage is a starting point for planning, not a fixed sentence; treatment, tumor biology, and follow-up all shape what happens next.

Common questions

For a localized tumor, Breslow thickness — how deep the melanoma reaches, in millimetres — is the single most important measurement, because it drives both the stage and how wide the surgery needs to be. Whether the surface is ulcerated matters too. It is worth asking your care team for your exact thickness and whether it is final.

Yes. Stage 0, or melanoma in situ, is genuine melanoma, but it is confined to the skin's outer layer and has not gained the ability to spread. It is removed surgically with a margin of normal skin. Being diagnosed at Stage 0 is the most favorable point at which melanoma is caught, which is the whole argument for early detection.

Not necessarily. Stage reflects how far a melanoma has spread and how thick it is, not how quickly it got there. Some subtypes, such as nodular melanoma, grow downward fast and are found thicker; others sit thin for a long time. How fast a melanoma spreads varies, so stage is something measured, not timed.

It can. The first biopsy gives a provisional diagnosis and thickness, but the wider excision that follows, and a sentinel lymph node biopsy where one is done, can refine the stage up or down. That is why a preliminary pathology report is not the final word, and why the follow-up appointment matters as much as the first.

Your pathologist and care team, working from the tissue that was removed plus any imaging or lymph-node procedures. A stage cannot be read from a photo, a symptom, or a search result. If you are still waiting on a stage, the honest answer is that it comes from the lab and the clinic, not from anything you can measure yourself.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

When a mole needs to be looked at

  • —A mole that is changing in size, shape, or color, or that looks unlike your others
  • —A new dark spot, or an existing one that becomes asymmetric, develops an irregular or blurred border, or shows more than one color
  • —A mole that itches, bleeds, crusts, or won't heal
  • —A new or growing dark streak under a nail, or a dark spot on the palm, sole, or inside the mouth

This article explains what the stages of melanoma mean in general terms. It cannot stage a melanoma or estimate any individual's outlook — only your pathology report and care team can do that. If you have a mole or spot you are worried about, the step that matters is having it examined in person.

References

  1. 1.Gershenwald JE, Scolyer RA, Hess KR, et al. (2017). Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA: A Cancer Journal for Clinicians. doi:10.3322/caac.21409AJCC eighth-edition melanoma staging: stage groups 0 to IV built from tumor thickness (Breslow) and ulceration (T), lymph-node status (N), and distant metastasis (M), and the eighth-edition revisions to these cutoffs and stage groupings.
  2. 2.National Cancer Institute (PDQ Adult Treatment Editorial Board) (2025). Melanoma Treatment (PDQ®)–Health Professional Version. NIH / National Cancer Institute. link ✓NCI PDQ that melanoma is diagnosed and staged from pathology, that melanoma in situ is confined to the epidermis and treated by excision, that sentinel lymph node biopsy assesses regional spread, and that immunotherapy and targeted therapy are standard for regional and distant disease.
  3. 3.American Family Physician (2011). Shave and Punch Biopsy for Skin Lesions. American Family Physician. link ✓For suspected melanoma, narrow full-thickness excisional or saucerization biopsy is preferred over superficial shave or partial punch because a partial sample can under-measure Breslow thickness and reduce staging accuracy.
  4. 4.Swetter SM, Tsao H, Bichakjian CK, et al. (2019). Guidelines of care for the management of primary cutaneous melanoma. Journal of the American Academy of Dermatology. doi:10.1016/j.jaad.2018.08.055AAD melanoma guideline on preferred excisional/narrow-margin biopsy technique, surgical excision margins chosen by tumor thickness (wide local excision), staged excision or Mohs for lentigo maligna, and the role of sentinel lymph node biopsy.
  5. 5.Faries MB, Thompson JF, Cochran AJ, et al. (2017). Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma. New England Journal of Medicine. doi:10.1056/NEJMoa1613210MSLT-II randomized trial: immediate completion lymph-node dissection after a positive sentinel node improved regional control and gave prognostic information but did not improve melanoma-specific survival versus nodal observation, supporting observation as an option.
  6. 6.National Cancer Institute, Surveillance, Epidemiology, and End Results (SEER) Program (2025). Cancer Stat Facts: Melanoma of the Skin. NIH / National Cancer Institute (SEER). linkSEER melanoma statistics: five-year relative survival is high for localized disease and progressively lower for regional and distant spread.

6 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — citations link their sources. Editorial policy

← Back to the health library